Our Decentralized Clinical Trial (DCT) Platform

The DCT platform with the most experience.

Right-size how your protocol is decentralized with Medable.

Platform modules fit to protocol.

TeleConsent, TeleCOA, and TeleVisit are the foundation

Complement site visits with fit-for-protocol modules

Access on-site and at-home on any web-enabled device

Compliance and security at the core.

Medable’s platform is secure, compliant, and scalable

Built with the highest standards of data privacy and security

Includes FDA 21 CFR Part 11, HIPAA, GDPR, and more.

Flexible. Modular. Medable.

Human Centric

Give patients an app that fits within their daily lives.

Building Blocks

Use only modules you want, on any study, and any device.

Enable Science

Discover the industry’s most flexible DCT platform.

One System

Gain the ability to run decentralized trials from one system.

A DCT model recruited three times as many patients three times faster than the traditional model.

NCBI

NCBI

National Center for Biotechnology Information

NCBI

National Center for Biotechnology Information
NCBI

NCBI

National Center for Biotechnology Information

Why Medable?

90%+

User app satisfaction

1M

Participants on platform

150+

Studies across 60+ countries

10-14

Weeks accelerated development